PMCB PharmaCyte Biotech
- 1.987
- -0.018-0.89%
- 1.990
- +0.003+0.14%
PharmaCyte Biotech News
PharmaCyte Biotech Announces $7 Million Strategic Investment in MYMD
PharmaCyte Biotech Interim CEO Silverman to Join Femasys Board >PMCB FEMY
PharmaCyte Biotech Interim CEO Silverman to Join Femasys Board >PMCB FEMY
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has
Femasys Secures $6.85M Additional Financing With Strategic Investment From Investors Led By PharmaCyte Biotech
Femasys Secures $6.85M Additional Financing With Strategic Investment From Investors Led By PharmaCyte Biotech
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunities PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the
PharmaCyte Completes Tender Offer to Purchase Shares
PharmaCyte Biotech Announces Final Results of Tender Offer
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") today announces the final results of its previously announced tender offer to acquire up to 7,750,00
Pancreatic Cancer Action Network Urges Advocates From All 50 States To Call On Congress To Increase Federal Funding For Pancreatic Cancer Research
Federal Funding Increases Fuel Research Progress and Help Improve Patient OutcomesLOS ANGELES, June 14, 2023 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading pancreatic cancer
PharmaCyte Biotech Shares Up 13% to 52-Week High After Cash Tender Offer
By Chris Wack PharmaCyte Biotech shares were up 13% to $3.10, its 52-week high, after the company said it launched a cash tender offer for up to 7.75 million shares at $3.25 a share. The stock is up
Organogenesis, Arcturus Top Healthcare Gainers; ImmunityBio, Dynatronics Among Losers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersSunshine Biopharma (NASDAQ:SBFM) shares rose 45.1% to $0.77 during Thursday's pre-market session. The company's market cap stands at $17.3 million. Jaguar Health (NASDAQ:JAGX) stock rose 28.19%
PharmaCyte Biotech Completes $35M Private Placement >PMCB
PharmaCyte Biotech Completes $35M Private Placement >PMCB
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share
Concurrently, the Company Announces $35 Million Financing of Convertible Preferred Stock at $4.00 per ShareLAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Com
Omega Therapeutics (NASDAQ:OMGA) & PharmaCyte Biotech (OTCMKTS:PMCBD) Head to Head Contrast
Omega Therapeutics (NASDAQ:OMGA – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two c
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Down 0.7%
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) traded down 0.7% during mid-day trading on Wednesday . The stock traded as low as $2.93 and last traded at $2.96. 33,345 shares traded hands during
PharmaCyte Biotech (OTCMKTS:PMCB) and Ocugen (NASDAQ:OCGN) Critical Review
Ocugen (NASDAQ:OCGN – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on t
Cortexyme (NASDAQ:CRTX) Versus PharmaCyte Biotech (OTCMKTS:PMCB) Critical Survey
PharmaCyte Biotech (OTCMKTS:PMCB – Get Rating) and Cortexyme (NASDAQ:CRTX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based o
Cortexyme (NASDAQ:CRTX) and PharmaCyte Biotech (OTCMKTS:PMCB) Financial Comparison
Cortexyme (NASDAQ:CRTX – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses b
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 0.4%
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) shares traded up 0.4% on Tuesday . The company traded as high as $2.88 and last traded at $2.84. 33,197 shares traded hands during mid-day trading,
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 0.4% Higher
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating)'s stock price traded up 0.4% during trading on Tuesday . The stock traded as high as $2.88 and last traded at $2.84. 33,197 shares changed hands dur
Analysis
Price Target
No Data
